Renaissance Technologies LLC Raises Holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Renaissance Technologies LLC lifted its holdings in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 4.2% during the second quarter, according to its most recent disclosure with the SEC. The fund owned 373,802 shares of the company’s stock after acquiring an additional 15,100 shares during the period. Renaissance Technologies LLC owned approximately 0.75% of Prestige Consumer Healthcare worth $25,736,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of PBH. Opal Wealth Advisors LLC purchased a new stake in Prestige Consumer Healthcare in the second quarter valued at approximately $26,000. Principal Securities Inc. purchased a new stake in Prestige Consumer Healthcare in the fourth quarter valued at approximately $29,000. Quest Partners LLC boosted its position in Prestige Consumer Healthcare by 2,826.7% in the second quarter. Quest Partners LLC now owns 439 shares of the company’s stock valued at $30,000 after buying an additional 424 shares during the last quarter. EverSource Wealth Advisors LLC boosted its position in Prestige Consumer Healthcare by 80.6% in the first quarter. EverSource Wealth Advisors LLC now owns 466 shares of the company’s stock valued at $33,000 after buying an additional 208 shares during the last quarter. Finally, Gladius Capital Management LP purchased a new stake in Prestige Consumer Healthcare in the second quarter valued at approximately $35,000. Hedge funds and other institutional investors own 99.95% of the company’s stock.

Analyst Ratings Changes

Separately, DA Davidson upped their target price on Prestige Consumer Healthcare from $93.00 to $95.00 and gave the company a “buy” rating in a research report on Wednesday, August 28th. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Prestige Consumer Healthcare presently has a consensus rating of “Moderate Buy” and an average target price of $98.75.

Prestige Consumer Healthcare Trading Up 0.6 %

Shares of NYSE:PBH opened at $73.94 on Friday. Prestige Consumer Healthcare Inc. has a 12-month low of $56.34 and a 12-month high of $75.80. The company has a market capitalization of $3.66 billion, a PE ratio of 17.73, a PEG ratio of 2.06 and a beta of 0.48. The business has a 50 day moving average of $71.16 and a two-hundred day moving average of $69.67. The company has a current ratio of 3.23, a quick ratio of 1.90 and a debt-to-equity ratio of 0.65.

Prestige Consumer Healthcare (NYSE:PBH) last announced its quarterly earnings results on Thursday, August 8th. The company reported $0.90 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.86 by $0.04. Prestige Consumer Healthcare had a return on equity of 12.55% and a net margin of 18.43%. The company had revenue of $267.10 million during the quarter, compared to the consensus estimate of $260.54 million. During the same period in the previous year, the company posted $1.06 earnings per share. Prestige Consumer Healthcare’s revenue for the quarter was down 4.4% on a year-over-year basis. As a group, analysts forecast that Prestige Consumer Healthcare Inc. will post 4.42 EPS for the current year.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.